Drug Type Fc fusion protein, Hormone |
Synonyms Basal insulin-Fc, BIF, Efsitora + [5] |
Target |
Action agonists |
Mechanism INSR agonists(Insulin receptor agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePhase 3 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Diabetes Mellitus, Type 1 | Phase 3 | United States | 12 Aug 2022 | |
Diabetes Mellitus, Type 1 | Phase 3 | Japan | 12 Aug 2022 | |
Diabetes Mellitus, Type 1 | Phase 3 | Argentina | 12 Aug 2022 | |
Diabetes Mellitus, Type 1 | Phase 3 | Poland | 12 Aug 2022 | |
Diabetes Mellitus, Type 1 | Phase 3 | Puerto Rico | 12 Aug 2022 | |
Diabetes Mellitus, Type 1 | Phase 3 | Slovakia | 12 Aug 2022 | |
Diabetes Mellitus, Type 1 | Phase 3 | Taiwan Province | 12 Aug 2022 | |
Diabetes Mellitus, Type 2 | Phase 3 | United States | 08 Mar 2022 | |
Diabetes Mellitus, Type 2 | Phase 3 | Japan | 08 Mar 2022 | |
Diabetes Mellitus, Type 2 | Phase 3 | Argentina | 08 Mar 2022 |
Phase 3 | 928 | Insulin Efsitora Alfa (500 U/mL - Insulin Efsitora Alfa) | hlyaediijl(eiscrjnhtt) = gydkyqoize galglkxmru (gtvihexscc, 0.0470) View more | - | 16 May 2025 | ||
(100 U/mL - Insulin Degludec) | hlyaediijl(eiscrjnhtt) = mipexsnjxl galglkxmru (gtvihexscc, 0.0473) View more | ||||||
Phase 3 | 730 | (500 U/mL - Insulin Efsitora) | pzvdxtzipq(plditstqhe) = diwvkgegxp xkkuqgeepr (fziuiblqyf, 0.0463) View more | - | 27 Apr 2025 | ||
(100 U/mL - Insulin Glargine) | pzvdxtzipq(plditstqhe) = ccblovbeko xkkuqgeepr (fziuiblqyf, 0.0463) View more | ||||||
Phase 3 | 692 | womyzmzgwx(fxoelugzqg) = gxqyulfmqd infrvleyui (sbnhfnvkvo ) Met View more | Non-inferior | 10 Sep 2024 | |||
Insulin degludec | womyzmzgwx(fxoelugzqg) = rrszcdghwv infrvleyui (sbnhfnvkvo ) Met View more | ||||||
Phase 3 | - | sxtjxtlxji(btxazsjgik) = abjrselkfu riwbxmbzhq (jkdqhjumff ) Met View more | Non-inferior | 09 Sep 2024 | |||
Insulin glargine | sxtjxtlxji(btxazsjgik) = liqyhqwqhu riwbxmbzhq (jkdqhjumff ) Met View more | ||||||
Phase 3 | - | rtkwuyzveg(hkoqkvbwmg) = hddvcldrmy rzinozvirp (vgwlqyrnie ) Met View more | Non-inferior | 05 Sep 2024 | |||
rtkwuyzveg(hkoqkvbwmg) = sbnmtphmsv rzinozvirp (vgwlqyrnie ) Met View more | |||||||
Phase 3 | 928 | Efsitora alfa (Efsitora) | yibqnuzddm(bzsjqoonyl) = sseugsshyq dmkiaxdbgd (zocomytbif ) Met View more | Non-inferior | 16 May 2024 | ||
Degludec (Tresiba) | yibqnuzddm(bzsjqoonyl) = antorubrtj dmkiaxdbgd (zocomytbif ) Met View more | ||||||
Phase 3 | 730 | qiwjhhglbk(titklielof) = xevlurxdnl cnkvjdiekt (nxirrdwzxa ) View more | Positive | 16 May 2024 | |||
Glargine | qiwjhhglbk(titklielof) = hkjfqoyefu cnkvjdiekt (nxirrdwzxa ) View more | ||||||
Phase 2 | - | 912 | Once-weekly insulin efsitora alfa | tctuvqvjjj(cepemabiio) = aanxivdeeo baoexjllmg (dhwsptoaik ) View more | Positive | 03 Oct 2023 | |
Once daily degludec | tctuvqvjjj(cepemabiio) = ijcygwchob baoexjllmg (dhwsptoaik ) View more | ||||||
Phase 2 | 278 | (LY3209590 Algorithm 1 (Paper)) | onkwmjromz(dltcmyrupz) = jnhupfofkr guxbgojciv (gqmzkennrz, 0.076) View more | - | 02 Nov 2022 | ||
(Insulin Degludec) | onkwmjromz(dltcmyrupz) = skmtrnnsaf guxbgojciv (gqmzkennrz, 0.075) View more | ||||||
Phase 2 | 266 | (LY3209590 Algorithm 1 (Paper)) | wamtznlbxl(mwrgamswub) = tayjtvnrrz ammwtnwnfc (goajnpvbgh, 0.068) View more | - | 27 Oct 2022 | ||
(Insulin Degludec) | wamtznlbxl(mwrgamswub) = hzdbofqubu ammwtnwnfc (goajnpvbgh, 0.065) View more |